Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 24, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	225,035	159,100	-	-	-	-
Enterprise Value	222,232	157,079	-	-	-	-
Last Close Price	2151.05	1512.33	-	-	-	-
PE Ratio	68.61	51.64	-	-	-	-
Forward PE	52.10	43.46	-	-	-	-
PS Ratio	20.72	15.65	-	-	-	-
PB Ratio	14.15	10.42	-	-	-	-
P/TBV Ratio	13.38	10.42	-	-	-	-
P/FCF Ratio	116.07	88.50	-	-	-	-
P/OCF Ratio	71.01	59.93	-	-	-	-
PEG Ratio	1.85	1.42	-	-	-	-
EV/Sales Ratio	20.47	15.45	-	-	-	-
EV/EBITDA Ratio	47.67	35.81	-	-	-	-
EV/EBIT Ratio	53.88	40.61	-	-	-	-
EV/FCF Ratio	114.62	87.37	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.01	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	0.02	0.05	0.31	1.19	-	-
Asset Turnover	0.65	0.63	0.60	0.57	0.58	-
Inventory Turnover	1.17	1.16	0.94	0.99	0.88	-
Quick Ratio	4.43	4.55	2.43	2.71	3.92	3.45
Current Ratio	6.60	6.30	3.79	4.08	5.74	4.68
Return on Equity (ROE)	22.27%	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	15.58%	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.39%	16.92%	15.07%	12.70%	19.78%	-
Earnings Yield	1.46%	1.94%	-	-	-	-
FCF Yield	0.86%	1.13%	-	-	-	-
Dividend Yield	0.41%	0.58%	-	-	-	-
Payout Ratio	27.91%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.45%	0.58%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.